IceCure Medical is thrilled to participate as a Gold Sponsor in the 2022 European Conference on Interventional Oncology (ECIO) Meeting in Austria, Vienna from April 24 – 27. We have an exciting program of events, including several hands on sessions, scientific poster presentations, and a breakfast symposium moderated by Professor Franco Orsi, MD, PhD.
IceCure representatives will be onsite to show you all the benefits our ProSense Cryoablation System has to offer and answer any of your questions about our liquid nitrogen based technology. Come visit us at Booth #10.
Our breakfast symposium “Liquid Nitrogen Based Cryoablation for Optimal Tumor Destruction” on Monday, April 25 at 8:00AM will be moderated by Professor Franco Orsi, MD, PhD. Professor Orsi will provide a concise overview and rational for performing cryoablation procedures. He will be joined by Dr. Yair Halpern, Specialist in Invasive Radiology and Director of the Invasive Radiology Clinic at Bnei Zion Hospital, Haifa, Israel, and Dr Ghizlane Touimi Benjelloun, Praticien Attaché Associé, Service de Radiologie et Imagerie Médicale, CHU de Nîmes, France who will share their case experiences with the ProSense liquid nitrogen system for a variety of clinical applications.
Dr. Kenneth R. Tomkovich, Co-Primary Investigator of the ICE3 trial, will present a scientific paper “Cryoablation of Low-Risk Breast Cancer: An Update of the ICE3 Trial” on Tuesday, April 26 from 3:00 PM – 4:30 PM (Vienna) in Auditorium 2.
IceCure will participate in the cryoablation hands on training sessions with the ProSense System. To learn more, visit ECIO 2022 on how to participate.
- Sunday, April 24 8:30 – 10:00
- Monday, April 25 17:00 – 18:30
- Tuesday, April 26 10:30 – 12:00
